Abstract:Ethnopharmacological relevance: Lung cancer is the leading cause of cancer incidence and mortality worldwide. Arenobufagin (Arg), a representative natural bufadienolide compound, is one of the major bioactive components isolated from toad venom ("Chan Su"named in Chinese to treat multifarious clinical neoplasms in China). However, the underlying molecular mechanisms that Arg inhibited the metastasis of lung cancer cells remain poorly understood. Materials and methods: The mobility capacities of lung cancer cells treated with Arg were evaluated using wound healing assay. The anti-migratory and anti-invasive effects of Arg on lung cancer cells were investigated by transwell invasion assay and matrigel invasion assay. iTRAQ-labeled LC-MS proteomics was used to analyze the potential proteins related to metastasis in lung cancer cells treated with Arg and differentially-expressed proteins related to EMT and NF kappa B signaling cascade were further confirmed by Western blotting assay. The changed subcellular localization of p65 in lung cancer A549 and H1299 cells treated with Arg was detected by immunofluorescence staining. Molecular docking and molecular dynamic (MD) simulation assay were performed to verify the binding between Arg and IKK alpha/IKK beta. siRNA knockdown was used to check whether Arg inhibited EMT of lung cancer cells via targeting NF kappa B signaling cascade, which was further verified by in vivo study of lung cancer cell xenograft mice model and pulmonary metastasis mice model accompanying with immunohistochemical and hematoxylin-eosin (HE) staining. Results: Arg suppressed the wound closure of lung cancer cells using wound healing assay. Moreover, Arg significantly inhibited the migration and invasion of lung cancer cells by transwell invasion assay and matrigel invasion assay. 24 unique differentially-expressed proteins related to metastasis in lung cancer cells treated with Arg were identified using iTRAQ-labeled LC-MS proteomics and 14 differentially-expressed proteins related to EMT were further confirmed by Western blotting assay. Arg significantly decreased the phosphorylation of IKK beta and p65 in the cytoplasm of lung cancer cells by Western blotting assay, and remarkably reduced the release of p65 from the cytoplasm to the nucleus. Arg could be bound in the ATP binding pocket of IKK alpha and IKK beta by molecular docking assay, and MD simulation assay further demonstrated that Arg binding to the ATPb-inding pocket of IKK beta was very stable in 300 ns MD simulation, compared with the binding of Arg and IKK alpha. IKK beta/NF kappa B signaling cascade was also involved in the inhibitory effect of Arg on EMT of lung cancer cells by siRNA knockdown assay. The study of lung cancer cell xenograft mice model and pulmonary metastasis mice model in vivo indicated that Arg inhibited EMT and suppressed migration and invasion of lung cancer cells via downregulating IKK beta/NF kappa B signaling cascade. Conclusion: In the present study, we explored the molecular mechanism of Arg prohibiting the metastasis of lung cancer cells in vitro and in vivo, which displayed Arg could target IKK beta to inactive NR kappa B signaling cascade and further change the expression of proteins related to EMT. These results highlight the potential of toad venom as a potential chemotherapeutic agent and warrant its development as the clinical therapy for lung cancer.

Integrated in Silico and Experimental Methods Revealed That Arctigenin Inhibited Angiogenesis and HCT116 Cell Migration and Invasion Through Regulating the H1F4A and Wnt/β-catenin Pathway

Arctigenin: Pharmacology, Total Synthesis, and Progress in Structure Modification

Arctigenin inhibits the progression of colorectal cancer through epithelial-mesenchymal transition via PI3K/Akt/mTOR signaling pathway

Effects of Arctigenin in Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma 5-8F Cells

ANGPTL1 Attenuates Colorectal Cancer Metastasis by Up-Regulating Microrna-138

Anti-colorectal cancer of Ardisia gigantifolia Stapf. and targets prediction via network pharmacology and molecular docking study

Arctigenin Inhibits Glioblastoma Proliferation Through the AKT/mTOR Pathway and Induces Autophagy

Apigenin inhibits migration and invasion via modulation of epithelial mesenchymal transition in prostate cancer.

The therapeutic potential of arctigenin against multiple human diseases: A mechanistic review

Arctigenin upregulates apoptosis through the AKT/MTOR pathway, inhibiting the proliferation of glioma

Preclinical Evidence that Arctigenin Effectively and Selectively Targets Clear Cell Renal Cell Carcinoma Via Suppressing EGFR and RhoA

Arnicolide C Suppresses Tumor Progression by Targeting 14-3-3θ in Breast Cancer

Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway.

Artemisia argyi Essential Oil Inhibits Hepatocellular Carcinoma Metastasis via Suppression of DEPDC1 Dependent Wnt/β-Catenin Signaling Pathway

Arenobufagin, Isolated from Toad Venom, Inhibited Epithelial-to-mesenchymal Transition and Suppressed Migration and Invasion of Lung Cancer Cells Via Targeting IKKβ/NFκB Signal Cascade.

Dandelion Polysaccharide Exerts Anti-Angiogenesis Effect on Hepatocellular Carcinoma by Regulating VEGF/HIF-1α Expression

A novel angiogenesis-based molecular signature related to prognosis and tumor immune interactions of pancreatic cancer

Elucidating the role of angiogenesis-related genes in colorectal cancer: a multi-omics analysis

Isolation and anti-neuroinflammation activity of sesquiterpenoids from Artemisia argyi: computational simulation and experimental verification

Identification of Novel Anoikis-Related Gene Signatures to Predict the Prognosis, Immune Microenvironment, and Drug Sensitivity of Breast Cancer Patients

Anthraquinone metabolites isolated from the rhizosphere soil Streptomyce s of Panax notoginseng (Burk.) F. H. Chen target MMP2 to inhibit cancer cell migration